AstroNova posts stronger FY26 results, trims loss

AstroNova, Inc. reported fiscal 2026 fourth-quarter revenue of $37.5 million, essentially flat year over year, as stronger Product Identification sales offset slightly lower Aerospace revenue.

Rhea-AI Filing Summary

AstroNova, Inc. reported fiscal 2026 fourth-quarter revenue of $37.5 million, essentially flat year over year, as stronger Product Identification sales offset slightly lower Aerospace revenue. Quarterly gross margin slipped to 30.2%, and the company posted a net loss of $1.1 million, or $(0.15) per share, a much smaller loss than the prior year’s impairment-affected results.

For the full year, revenue was $150.5 million and net loss improved significantly to $2.4 million from $14.5 million, while Adjusted EBITDA rose to $12.7 million with an 8.4% margin. Operating cash flow reached $11.7 million, helping reduce debt to $37.6 million as of January 31, 2026.

Product ID segment revenue grew to $104.2 million, with aftermarket sales around 80% of the segment, while Aerospace delivered $46.3 million of revenue and a 21.1% operating margin. Management highlighted strong Aerospace bookings and backlogs in both segments, and noted that a major Aerospace royalty obligation expiring in the third quarter of fiscal 2027 is expected to add about $2 million to annual gross profit. For fiscal 2027, the company targets mid‑single‑digit revenue growth and higher adjusted EBITDA margin.

Positive

• Profitability and cash flow improved materially: Fiscal 2026 net loss narrowed to $2.4 million from $14.5 million, Adjusted EBITDA rose to $12.7 million (8.4% margin), and operating cash flow reached $11.7 million.
• Balance sheet strengthened: Total debt declined to $37.6 million from $46.7 million as of January 31, 2025, supported by improved cash generation.
• High-quality segment performance and visibility: Product ID revenue grew to $104.2 million with ~80% aftermarket mix, Aerospace delivered a 21.1% operating margin, and both segments reported healthy bookings and backlog.
• Future margin tailwind identified: Expiration of a major Aerospace royalty obligation in Q3 fiscal 2027 is expected to increase annual gross profit by approximately $2 million starting in Q4 fiscal 2027.

Negative

• None.

Insights

Equity analyst – industrial technology

AstroNova shows early turnaround signs with stronger cash flow, margin repair, and constructive 2027 outlook.

AstroNova delivered flat Q4 revenue at $37.5 million but sharply improved profitability versus last year’s impairment-heavy quarter. Full‑year net loss narrowed to $2.4 million from $14.5 million, and $12.7 million Adjusted EBITDA at a 8.4% margin signals core operations are healthier.

Cash generation stands out: operating cash flow of $11.7 million in fiscal 2026 enabled debt reduction from $46.7 million to $37.6 million. Product ID revenue grew to $104.2 million with a recurring aftermarket mix around 80%, while Aerospace maintained a strong 21.1% operating margin despite modest revenue decline.

Management points to additional upside from a major Aerospace royalty obligation expiring in Q3 fiscal 2027, expected to lift annual gross profit by about $2 million from Q4 fiscal 2027 onward. Combined with guidance for mid‑single‑digit revenue growth and expanded adjusted EBITDA margin in fiscal 2027, the filing portrays a business transitioning from restructuring toward steadier, more profitable growth, although execution on Product ID growth and Aerospace order timing remains crucial.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Q4 2026 Revenue: $37.5M FY 2026 Revenue: $150.5M FY 2026 Net Loss: $2.4M +5 more

8 metrics

Q4 2026 Revenue $37.5M Three months ended January 31, 2026

FY 2026 Revenue $150.5M Twelve months ended January 31, 2026

FY 2026 Net Loss $2.4M Improved from $14.5M net loss in fiscal 2025

FY 2026 Adjusted EBITDA $12.7M Adjusted EBITDA margin 8.4% for fiscal 2026

Debt Balance $37.6M Debt as of January 31, 2026, down from $46.7M

Product ID Revenue $104.2M Segment revenue for fiscal 2026

Aerospace Operating Margin 21.1% Aerospace segment operating margin, fiscal 2026

Royalty Benefit $2M Expected annual gross profit uplift after Q3 fiscal 2027 royalty expiry

Key Terms

Adjusted EBITDA, Non-GAAP gross profit, book-to-bill ratio, backlog, +2 more

6 terms

Adjusted EBITDA financial

"Adjusted EBITDA was $3,306 and Adjusted EBITDA margin was 8.8%."

Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.

Non-GAAP gross profit financial

"Non-GAAP Gross Profit | $ 11,903 | $ 12,289 |"

Non-GAAP gross profit is a way companies measure how much money they make from selling their products or services, excluding some expenses that are usually included in standard calculations. It matters because it can give a clearer picture of the company's core earning ability, helping investors understand its performance without certain accounting adjustments.

book-to-bill ratio financial

"The book-to-bill ratio for the segment was 104% and backlog at the end of fiscal 2026 was $13.5 million."

The book-to-bill ratio compares the value of new orders a company receives to the value of products it ships out or bills for over a certain period. If the ratio is above 1, it means the company is getting more orders than it is completing, which can indicate growth. If it's below 1, it suggests demand is slowing down.

backlog financial

"Backlog at the end of fiscal 2026 was $12.0 million."

A backlog is the amount of work or orders that a company has received but hasn't completed yet. It’s like a restaurant with many dishes to serve; the backlog shows how many orders are still waiting to be finished. It matters because a large backlog can indicate strong demand or potential delays in delivering products or services.

royalty obligation financial

"a major royalty obligation for Aerospace will expire in the third quarter this year that will provide an annualized contribution to gross profit of approximately $2 million"

A royalty obligation is a legal promise to pay a continuing fee—often a percentage of sales or a fixed amount—for the right to use someone else’s asset, such as a patent, trademark, mineral rights, or technology. Think of it like paying rent for a tool or recipe: it reduces the owner’s available profits and creates an ongoing cash outflow that can affect a company’s earnings, valuation, and risk profile, so investors watch them to gauge future cash flow and profitability.

segment operating income financial

"Aerospace segment operating profit was $2.3 million, up $0.5 million, or 24.0%"

Segment operating income is the profit a company earns from one specific part of its business after subtracting the costs of running that part but before interest, taxes and corporate-level items. For investors, it shows which divisions are actually generating operating profit and lets you compare the health and efficiency of different business “slices,” much like checking the cash a single store in a chain makes before company-wide overhead is applied.

Earnings Snapshot

Revenue: $150.5M · Guidance included

Fiscal 2026

Revenue $150.5M -0.5% YoY

Net Income (Loss) ($2.4M) improved from ($14.5M)

Adjusted EBITDA $12.7M slightly up from $12.3M

Q4 Revenue $37.5M +0.5% YoY

Guidance

For fiscal 2027, management expects mid-single digit revenue growth and expanded adjusted EBITDA margin.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How did AstroNova (ALOT) perform in Q4 fiscal 2026?

AstroNova’s Q4 fiscal 2026 revenue was $37.5 million, essentially flat year over year. Gross margin fell to 30.2%, and the company reported a net loss of $1.1 million, or $(0.15) per share, but results improved sharply versus the prior year’s impairment-impacted quarter.

What were AstroNova’s full-year fiscal 2026 results?

For fiscal 2026, AstroNova generated $150.5 million in revenue and a net loss of $2.4 million, compared with a $14.5 million loss in fiscal 2025. Adjusted EBITDA increased to $12.7 million with an 8.4% margin, indicating stronger underlying operating performance.

How did AstroNova’s Product Identification segment perform in fiscal 2026?

The Product Identification segment delivered $104.2 million of revenue in fiscal 2026, up from $102.3 million the prior year. Aftermarket revenue remained strong, representing about 80% of segment sales, and segment non‑GAAP operating loss narrowed to $0.5 million, or 1.5% of revenue.

What were the key results for AstroNova’s Aerospace segment?

AstroNova’s Aerospace segment recorded fiscal 2026 revenue of $46.3 million, slightly below $48.9 million in fiscal 2025. Despite lower sales, Aerospace segment operating profit increased to $9.8 million, with operating margin improving to 21.1% on favorable product mix and strong bookings.

How is AstroNova’s balance sheet and cash flow position at year-end fiscal 2026?

At January 31, 2026, AstroNova held $4.1 million of cash and had $37.6 million of debt, down from $46.7 million a year earlier. Fiscal 2026 operating cash flow was $11.7 million, reflecting improved working capital, particularly lower inventories.

What outlook did AstroNova (ALOT) provide for fiscal 2027?

For fiscal 2027, AstroNova expects mid‑single‑digit revenue growth and expanded adjusted EBITDA margin. Management also highlighted that a major Aerospace royalty obligation expiring in the third quarter should add about $2 million to annual gross profit beginning in the fourth quarter.

What is the significance of the royalty obligation expiring for AstroNova?

A major royalty obligation in the Aerospace business is scheduled to expire in the third quarter of fiscal 2027. The company estimates this will improve annual gross profit by roughly $2 million, beginning in Q4 fiscal 2027, supporting future margin expansion.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/14/2026 - 06:02 AM EDT Learn about SEC filing dates

false 0000008146 0000008146 2026-04-13 2026-04-13

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported): April 13, 2026

ASTRONOVA, INC.

(Exact name of registrant as specified in its charter)

Rhode Island		0-13200		05-0318215
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

600 East Greenwich Avenue

West Warwick, RI 02893

(Address of principal executive offices) (Zip Code)

(401) 828-4000

Registrant’s telephone number, including area code

Not applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol(s)		Name of Each Exchange on which Registered
Common Stock, $0.05 Par Value		ALOT		NASDAQ Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On April 13, 2026, we issued a press release reporting the financial results for our fiscal fourth quarter and full year ended January 31, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information contained in Item 2.02 of this report and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statement and Exhibits.

(d) Exhibits

Exhibit No.		Exhibit
99.1		Press Release dated April 13, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

				ASTRONOVA, INC.
Dated: April 14, 2026				By:		/s/ Thomas D. DeByle
						Thomas D. DeByle
						Vice President, Chief Financial Officer and Treasurer

Exhibit 99.1

  News Release  

FOR IMMEDIATE RELEASE

AstroNova Reports Fourth-Quarter and Full-Year

Fiscal 2026 Financial Results

• Fourth quarter revenue of $37.5 million and fiscal 2026 revenue of $150.5 million, in line with guidance

• Fourth quarter net loss was $1.1 million, or $0.15 per diluted share; adjusted EBITDA¹ was $3.3 million, or 8.8% of sales

• Product Identification turnaround gaining momentum with well-defined go-to-market and operations strategies

• Total orders in the quarter were up 6.5% to $41.1 million

• Generated $3.7 million of operating cash in the quarter and $11.7 million for the full year, compared with $2.5 million and $4.8 million in the prior periods, respectively

• Strengthened balance sheet with debt reduced by $2.7 million in the quarter and $9.1 million in fiscal 2026

• Previously announced evaluation of strategic alternatives

West Warwick, R.I., April 13, 2026 – AstroNova, Inc. (Nasdaq: ALOT), a leading innovator in specialized print technology solutions, today announced financial results for its fiscal 2026 fourth quarter and full-year ended January 31, 2026.

Jorik Ittmann, President and Chief Executive Officer of AstroNova, stated, “The second half of fiscal 2026 was a reset period for AstroNova. As we began the year, we recognized that the changes we were making in the business would begin to be realized with a stronger second half. Our focus was on stabilizing the business and ending the year having generated more cash, reduced debt, and raised accountability across both segments. Our Aerospace business delivered a strong performance, with ToughWriter now representing more than 80% of total flight deck printer shipments, positioning us well as aircraft build rates increase.

“In Product ID, we provide label printing solutions that address the needs of three key verticals: healthcare/life sciences, industrial and chemical industries. In these markets our labels are a component of customers’ products and are critical to their success. Our restructuring efforts are being realized through improving commercial momentum in these verticals. We have employed more robust analytics to understand our customers and markets and are better directing our resources to drive growth. This includes continuing to evolve the team, putting the right talent in the correct roles, and recognizing where and why we can win. We expect this focus of our resources where we have competitive advantages will lead to stronger, more profitable growth.”

¹  Non-GAAP gross profit, Non-GAAP gross profit margin, Non-GAAP operating income, Non-GAAP operating income margin, Non-GAAP net income, adjusted EBITDA and adjusted EBITDA margin are Non-GAAP financial measures. Refer to the reconciliation of GAAP to non-GAAP measures in the tables that accompany this news release.

-MORE-

AstroNova Inc. | 600 East Greenwich Avenue | West Warwick, RI 02893 | 401.828.4000

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 2 of 19

Mr. Ittmann added, “Looking ahead to fiscal 2027, we expect Aerospace to deliver measured growth, supported by rising aircraft production, a favorable product mix, and the expiration of a major royalty obligation during the third quarter of the year that negatively impacts gross margin on an annualized basis by approximately $2 million. In Product ID, we are focused on converting our commercial pipeline into consistent revenue growth while strengthening operational performance. We believe we can create greater value for our shareholders with our enhanced product offerings, go-to-market strategy and operational restructuring. Importantly, we will evaluate all strategic alternatives to achieve this goal.”

Fourth Quarter Fiscal 2026 Overview¹ (comparisons are to the prior-year period unless noted otherwise)

		Three Months Ended																2H Fiscal 2026 compared with 1H Fiscal 2026
		January 31, 2026				January 31, 2025				$ Variance				% Variance				2H FY26				1H FY26				$ Variance				% Variance
Revenue		$	37,536			$	37,361			$	175				0.5	%		$	76,705			$	73,810			$	2,895				3.9	%
Gross Profit		$	11,325			$	12,226			$	(901	)			(7.4	)%		$	24,769			$	22,865			$	1,902				8.3	%
Gross Profit Margin			30.2	%			32.7	%											32.3	%			31.0	%
Non-GAAP Gross Profit		$	11,903			$	12,289			$	(386	)			(3.1	)%		$	25,707			$	23,264			$	2,444				10.5	%
Non-GAAP Gross Profit Margin			31.7	%			32.9	%											33.5	%			31.5	%
Operating Income (Loss)		$	56			$	(12,311	)		$	12,367				(100.5	)%		$	1,342			$	(137	)		$	1,479				N/A
Operating Margin			0.1	%			(33.0	)%											1.7	%			(0.2	)%
Non-GAAP Operating Income		$	1,124			$	1,408			$	(284	)			(20.2	)%		$	3,688			$	1,906			$	1,781				93.4	%
Non-GAAP Operating Income Margin			3.0	%			3.8	%											4.8	%			2.6	%
Net Income (Loss)		$	(1,134	)		$	(15,600	)		$	14,466				(92.7	)%		$	(756	)		$	(1,620	)		$	864				53.3	%
Non-GAAP Net Income (Loss)		$	(305	)		$	419			$	(724	)			(172.7	)%		$	1,277			$	(59	)		$	1,336				N/A
Adjusted EBITDA		$	3,306			$	2,794			$	512				18.3	%		$	7,478			$	5,202			$	2,276				43.7	%
Adjusted EBITDA Margin			8.8	%			7.5	%											9.7	%			7.0	%

Compared with the prior-year period, revenue increased $0.2 million as growth in Product ID slightly exceeded lower Aerospace revenue. Tariff mitigation contributed $0.6 million in revenue and foreign currency translation was a $0.8 million benefit in the quarter.

As a result of lower volume and mix, gross profit decreased $0.9 million, or 7.4%, and gross margin contracted 250 basis points compared with the prior-year period. On an adjusted basis, gross margin contracted 120 basis points from the prior-year period to 32.9%.

Operating expenses in the quarter were $11.3 million down from $25.0 million in the prior-year period. The prior year period included a goodwill impairment charge of $13.4 million. Operating income for the quarter was $56 thousand compared with operating loss of $12.3 million in the prior-year period, while non-GAAP operating income was $1.1 million, down $0.3 million compared with the prior-year period.

Interest expense of $0.9 million was nominally unchanged from the prior-year period. Net loss of $1.1 million, or $0.15 per share, compared with net loss of $15.6 million in the prior-year period, which included a goodwill impairment charge of $13.4 million. Non-GAAP net loss was $0.3 million, or $0.04 per share. Adjusted EBITDA was $3.3 million and Adjusted EBITDA margin was 8.8%.

Beginning in the fourth quarter of fiscal 2026, the Company revised its segment reporting methodology to allocate related general and administrative expenses directly to the reportable segments, Product Identification and Aerospace. Management believes this change better reflects the true operating performance of each segment. Prior period segment results have been recast to reflect this change. The impact of this reallocation on segment operating income is presented in the segment tables that follow.

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 3 of 19

Product Identification (Product ID) Segment Review

Product ID revenue was $26.3 million for the fourth quarter of fiscal 2026, up 2.5%, or $0.7 million, compared with the prior year. Aftermarket revenue remained strong, representing approximately 80% of total segment sales.

Product ID segment operating loss was $0.2 million, an improvement from the segment operating loss of $13.1 million in the prior-year period which included the previously mentioned goodwill impairment charge. Non-GAAP segment operating loss was $0.1 million, or -0.5% of revenue.

Aerospace Segment Review

Aerospace segment revenue was $11.2 million in the fiscal 2026 fourth quarter, a decrease of 4.1%, or $0.5 million from the prior-year, primarily as a result of the timing of projects.

Despite lower sales, Aerospace segment operating profit was $2.3 million, up $0.5 million, or 24.0%, over the prior-year period as a result of improved mix.

Balance Sheet and Cash Flow

Cash from operations in the fourth quarter of fiscal 2026 was $3.7 million and was $11.7 million year to date. The improvement in cash generation in the quarter was primarily the result of reduced working capital requirements, primarily due to lower inventory.

Capital expenditures in the quarter were $139 thousand and $332 thousand for fiscal 2026 compared with $79 thousand and $1.2 million, respectively, in the prior year.

Cash at the end of the fourth quarter of fiscal 2026 was $4.1 million, down $0.9 million from the end of fiscal 2025. Debt as of January 31, 2026 was $37.6 million compared with $46.7 million as of January 31, 2025.

Bookings and Backlog by Segment

Orders in the quarter for the Product ID segment were $27.5 million, up $2.9 million compared with the prior-year period as the Company’s new go-to-market strategy gained traction. The book-to-bill ratio for the segment was 104% and backlog at the end of fiscal 2026 was $13.5 million.

Orders in the quarter for the Aerospace segment were $13.6 million for a book-to-bill ratio of 122% reflecting demand from OEMs for new-build aircraft. Backlog at the end of fiscal 2026 was $12.0 million.

Fiscal 2027 Outlook

“We are making solid progress with the improvement in our Product ID segment and are delivering on the potential of the Aerospace segment. As noted previously, a major royalty obligation for Aerospace will expire in the third quarter this year that will provide an annualized contribution to gross profit of approximately $2 million beginning in the fourth quarter. We are encouraged with our progress and believe we are creating greater opportunity for the business,” concluded Mr. Ittmann.

For fiscal 2027, AstroNova expects mid-single digit revenue growth and expanded adjusted EBITDA margin.

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 4 of 19

Earnings Conference Call Information

AstroNova will host a conference call and webcast at 8:30 a.m. ET on Tuesday, April 14, 2026, to review financial and operating results for the fourth quarter and full year of fiscal 2026. A question and answer session will follow. 

To access the conference call, please dial (201) 689-8560 or find the webcast and accompanying slide presentation at https://investors.astronovainc.com/investors/events-and-presentations/default.aspx.

A telephonic replay will be available from 12:00 p.m. ET on the day of the call through Tuesday, April 28, 2026. To listen to the archived call, dial (412) 317-6671 and enter a replay PIN 13759000. The webcast replay will be available on the Investor Relations section of the Company’s website where a transcript will be posted once available.

About AstroNova, Inc.

AstroNova (Nasdaq: ALOT) is a global provider of printing technologies serving regulated and industrial markets. The Company designs, manufactures, distributes, and services solutions that enable customers to identify, track, and communicate essential product and safety information across a wide range of applications and media. AstroNova supports customers by enabling safety, accuracy and durability for flight deck communications, medical device and healthcare products, essential chemical products, and mission-critical industrial components, while ensuring compliance with local and regional regulatory requirements.

The Product Identification segment delivers end-to-end marking and identification solutions, including hardware, software, and consumables for OEMs, commercial printers, and brand owners. These solutions are used across labels, flexible packaging, corrugated, and industrial substrates, where durability, traceability, and compliance are essential. The Aerospace segment is a global leader in providing products designed for airborne printing solutions, avionics, and data acquisition, including flight deck printing solutions, networking hardware, and specialized aerospace-grade supplies. For more information please visit: www.astronovainc.com.

Use of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this news release contains the Non-GAAP financial measures: Non-GAAP gross profit, Non-GAAP gross profit margin, Non-GAAP operating expenses, Non-GAAP operating income, Non-GAAP operating income margin, Non-GAAP net income (loss), Non-GAAP net income per Common Share - diluted, Non-GAAP segment gross profit, Non-GAAP segment gross profit margin, Non-GAAP segment operating income, Non-GAAP segment operating margin, Adjusted EBITDA and Adjusted EBITDA Margin. AstroNova believes that the inclusion of these Non-GAAP financial measures helps investors gain a meaningful understanding of changes in the Company’s core operating results and can help investors who wish to make comparisons between AstroNova and other companies on both a GAAP and a Non-GAAP basis. AstroNova’s management uses these Non-GAAP financial measures, in addition to GAAP financial measures, as the basis for measuring its core operating performance and comparing such performance to that of prior periods and to the performance of its competitors. These measures are also used by the Company’s management to assist with their financial and operating decision-making. Please refer to the financial reconciliation table included in this news release for a reconciliation of the Non-GAAP measures to the most directly comparable GAAP measures for the three months ended January 31, 2026 and 2025 as well as the years ended January 31, 2026 and 2025.

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 5 of 19

Forward-Looking Statements

Information included in this news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact but rather reflect our current expectations concerning future events and results. These statements may include the use of the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning the Company’s anticipated performance, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, (i) the risk that our efforts to improve sales in our Product Identification segment may not result in the benefits we expect, (ii) the risk that our Aerospace customers may not continue to convert to our ToughWriter^® printer in the volumes or on the schedule that we expect; (iii) the risk that we may not realize the anticipated benefits of our next-generation print engine technology; and (iv) those factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2025 and subsequent filings AstroNova makes with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The reader is cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this news release.

Contact:

Deborah Pawlowski, IRC, Alliance Advisors

Email: dpawlowski@allianceadvisors.com

Phone: 716.843.3908

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 6 of 19

ASTRONOVA, INC.

Condensed Consolidated Statements of Income (Loss)

(In thousands, except per share data)

(Unaudited)

		Three Months Ended
		January 31, 2026				January 31, 2025				$ Variance				% Variance
Revenue		$	37,536			$	37,361			$	175				0.5	%
Cost of Revenue			26,211				25,135				1,076				4.3	%
Gross Profit			11,325				12,226				(901	)			(7.4	)%
Total Gross Profit Margin			30.2	%			32.7	%
Operating Expenses:
Selling & Marketing			5,642				6,097				(455	)			(7.5	)%
Research & Development			1,797				1,617				180				11.1	%
General & Administrative			3,830				3,420				410				12.0	%
Goodwill Impairment			—				13,403				(13,403	)			(100.0	)%
Total Operating Expenses			11,269				24,537				(13,268	)			(54.1	)%
Operating Income (Loss)			56				(12,311	)			12,367				(100.5	)%
Total Operating Margin			0.1	%			(33.0	)%
Interest Expense			894				847				47				5.5	%
Other (Income)/Expense, net			(51	)			100				(151	)			(151.0	)%
Income (Loss) Before Taxes			(788	)			(13,258	)			12,470				(94.1	)%
Income Tax Provision (Benefit)			346				2,342				(1,996	)			(85.2	)%
Net Income (Loss)		$	(1,134	)		$	(15,600	)		$	14,466				(92.7	)%
Net Income (Loss) per Common Share - Basic		$	(0.15	)		$	(2.07	)
Net Income (Loss) per Common Share - Diluted		$	(0.15	)		$	(2.07	)
Weighted Average Number of Common Shares - Basic			7,653				7,534
Weighted Average Number of Common Shares - Diluted			7,653				7,534

		Twelve Months Ended
		January 31, 2026				January 31, 2025				$ Variance				% Variance
Revenue		$	150,515			$	151,283			$	(768	)			(0.5	)%
Cost of Revenue			102,881				100,625				2,256				2.2	%
Gross Profit			47,634				50,658				(3,024	)			(6.0	)%
Total Gross Profit Margin			31.6	%			33.5	%
Operating Expenses:
Selling & Marketing			22,963				24,252				(1,289	)			(5.3	)%
Research & Development			6,788				6,047				741				12.3	%
General & Administrative			16,380				15,596				784				5.0	%
Goodwill Impairment			297				13,403				(13,106	)			(97.8	)%
Total Operating Expenses			46,428				59,298				(12,870	)			(21.7	)%
Operating Income (Loss)			1,206				(8,640	)			9,846				(114.0	)%
Total Operating Margin			0.8	%			(5.7	)%
Interest Expense			3,503				3,210				293				9.1	%
Other (Income)/Expense, net			239				437				(198	)			(45.3	)%
Income (Loss) Before Taxes			(2,536	)			(12,287	)			9,751				(79.4	)%
Income Tax Provision (Benefit)			(160	)			2,202				(2,362	)			(107.3	)%
Net Income (Loss)		$	(2,376	)		$	(14,489	)		$	12,113				(83.6	)%
Net Income (Loss) per Common Share - Basic		$	(0.31	)		$	(1.93	)
Net Income (Loss) per Common Share - Diluted		$	(0.31	)		$	(1.93	)
Weighted Average Number of Common Shares - Basic			7,614				7,509
Weighted Average Number of Common Shares - Diluted			7,614				7,509

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 7 of 19

ASTRONOVA, INC.

Condensed Consolidated Balance Sheets

(In thousands)

(Unaudited)

		January 31, 2026				January 31, 2025
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents		$	4,072			$	5,050
Accounts Receivable, net			18,985				21,218
Inventories, net			43,252				47,894
Prepaid Expenses and Other Current Assets			4,395				3,855
Total Current Assets			70,704				78,017
PROPERTY, PLANT AND EQUIPMENT			40,400				58,613
Less Accumulated Depreciation			(26,272	)			(42,820	)
Property, Plant and Equipment, net			14,128				15,793
OTHER ASSETS
Identifiable Intangibles, net			21,496				23,519
Goodwill			17,376				16,361
Deferred Tax Assets, net			9,831				8,431
Right of Use Asset			2,466				1,781
Other Assets			1,565				1,693
TOTAL ASSETS		$	137,566			$	145,595
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts Payable		$	6,806			$	7,928
Accrued Compensation			4,390				3,745
Other Accrued Expenses			4,702				4,461
Revolving Line of Credit			16,273				20,929
Current Portion of Long-Term Debt			3,033				6,110
Short-Term Debt			—				581
Current Liability – Royalty Obligation			1,656				1,358
Current Liability – Excess Royalty Payment Due			331				691
Income Taxes Payable			691				—
Deferred Revenue			489				543
Total Current Liabilities			38,371				46,346
NON-CURRENT LIABILITIES
Long-Term Debt, net of current portion			18,295				19,044
Lease Liabilities, net of current portion			1,953				1,535
Grant Deferred Revenue			899				1,090
Royalty Obligation, net of current portion			145				1,106
Income Tax Payables			800				684
Deferred Tax Liabilities			—				40
Other Long-Term Liability			241				—
TOTAL LIABILITIES			60,704				69,845
SHAREHOLDERS’ EQUITY
Common Stock			554				547
Additional Paid-in Capital			66,329				64,215
Retained Earnings			47,004				49,380
Treasury Stock			(35,227	)			(35,043	)
Accumulated Other Comprehensive Loss, net of tax			(1,798	)			(3,349	)
TOTAL SHAREHOLDERS’ EQUITY			76,862				75,750
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY		$	137,566			$	145,595

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 8 of 19

ASTRONOVA, INC.

Condensed Consolidated Statements of Cash Flow

(In thousands)

(Unaudited)

		Three Months Ended
		January 31, 2026				January 31, 2025
Cash Flows from Operating Activities:
Net Income (Loss)		$	(1,134	)		$	(15,599	)
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:
Depreciation and Amortization			1,379				1,266
Grant Income Included in Depreciation			155				51
Goodwill Impairment			—				13,403
Amortization of Debt Issuance Costs			10				8
Share-Based Compensation			751				219
Deferred Income Tax Provision (Benefit)			(1,238	)			874
Loss on Disposal of Fixed Assets			3				—
Changes in Assets and Liabilities:
Accounts Receivable			1,566				1,240
Inventories			2,129				236
Income Taxes			1,764				630
Accounts Payable and Accrued Expenses			(758	)			(8	)
Deferred Revenue			(519	)			(440	)
Other			(434	)			645
Net Cash Provided by Operating Activities		$	3,673			$	2,525
Cash Flows from Investing Activities:
Proceeds from Sale of Equipment			13				—
Purchases of Property, Plant and Equipment			(139	)			(79	)
Cash Paid for MTEX Acquisition, net of cash acquired			—				—
Net Cash Used for Investing Activities		$	(126	)		$	(79	)
Cash Flows from Financing Activities:
Net Cash Proceeds from Employee Stock Option Plans			—				—
Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan			—				48
Net Cash Used for Payment of Taxes Related to Vested Restricted Stock			(1	)			(18	)
Revolving Credit Facility, net			(1,981	)			734
Proceeds from Long Term Debt Borrowings			—				—
Payment of Minimum Guarantee Royalty Obligation			(279	)			(655	)
Principal Payments of Long-Term Debt			(864	)			(2,274	)
Payments of Debt Issuance Costs			—				3
Net Cash Provided by (Used for) Financing Activities		$	(3,125	)		$	(2,163	)
Effect of Exchange Rate Changes on Cash and Cash Equivalents			44				336
Net Increase in Cash and Cash Equivalents		$	466			$	618
Cash and Cash Equivalents, Beginning of Period			3,606				4,432
Cash and Cash Equivalents, End of Period		$	4,072			$	5,050
Supplemental Information:
Cash Paid During the Period for:
Interest		$	751			$	810
Income Taxes, net of refunds			13			$	707
Non-Cash Transactions:
Operating Lease Obtained in Exchange for Operating Lease Liabilities		$	89			$	—

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 9 of 19

ASTRONOVA, INC.

Condensed Consolidated Statements of Cash Flow – Twelve Months Ended

(In thousands)

(Unaudited)

		Twelve Months Ended
		January 31, 2026				January 31, 2025
Cash Flows from Operating Activities:
Net Income (Loss)		$	(2,376	)		$	(14,489	)
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:
Depreciation and Amortization			4,804				4,780
Grant Income Included in Depreciation			330				159
Goodwill Impairment			297				13,403
Amortization of Debt Issuance Costs			43				30
Share-Based Compensation			2,310				1,378
Deferred Income Tax Provision (Benefit)			(1,312	)			874
Loss on Disposal of Fixed Assets			115				—
Changes in Assets and Liabilities:
Accounts Receivable			2,786				2,859
Inventories			5,909				1,616
Income Taxes			663				(904	)
Accounts Payable and Accrued Expenses			(1,125	)			(2,379	)
Deferred Revenue			(420	)			(1,520	)
Other			(286	)			(959	)
Net Cash Provided by Operating Activities		$	11,738			$	4,848
Cash Flows from Investing Activities:
Proceeds from Sale of Equipment			113				—
Purchases of Property, Plant and Equipment			(332	)			(1,165	)
Cash Paid for MTEX Acquisition, net of cash acquired			—				(19,109	)
Net Cash Used for Investing Activities		$	(219	)		$	(20,274	)
Cash Flows from Financing Activities:
Net Cash Proceeds from Employee Stock Option Plans			—				12
Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan			51				146
Net Cash Used for Payment of Taxes Related to Vested Restricted Stock			(184	)			(450	)
Revolving Credit Facility, net			(5,158	)			11,508
Proceeds from Long Term Debt Borrowings			19,720				15,078
Payment of Minimum Guarantee Royalty Obligation			(1,238	)			(1,902	)
Principal Payments of Long-Term Debt			(25,982	)			(8,980	)
Payments of Debt Issuance Costs			(66	)			(34	)
Net Cash Provided by (Used for) Financing Activities		$	(12,857	)		$	15,378
Effect of Exchange Rate Changes on Cash and Cash Equivalents			360				571
Net (Decrease) Increase in Cash and Cash Equivalents		$	(978	)		$	523
Cash and Cash Equivalents, Beginning of Period			5,050				4,527
Cash and Cash Equivalents, End of Period		$	4,072			$	5,050
Supplemental Information:
Cash Paid During the Period for:
Interest		$	3,043			$	2,701
Income Taxes, net of refunds			634				2,210
Non-Cash Transactions:
Operating Lease Obtained in Exchange for Operating Lease Liabilities		$	1,075			$	1,581

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 10 of 19

ASTRONOVA, INC.

Segment Sales and Profit

(Unaudited, $ in thousands)

		Three Months Ended								Twelve Months Ended
($ in thousands)		January 31, 2026				January 31, 2025				January 31, 2026				January 31, 2025
Revenue:
Product ID		$	26,330			$	25,678			$	104,221			$	102,345
Aerospace			11,206				11,683				46,294				48,938
Total Revenue		$	37,536			$	37,361			$	150,515			$	151,283
Gross Profit:
Product ID		$	7,088			$	8,237			$	29,837			$	32,571
Aerospace			4,237				3,989				17,797				18,087
Gross Profit		$	11,325			$	12,226			$	47,634			$	50,658
Gross Profit Margin:
Product ID			26.9	%			32.1	%			28.6	%			31.8	%
Aerospace			37.8	%			34.1	%			38.4	%			37.0	%
Gross Profit Margin			30.2	%			32.7	%			31.6	%			33.5	%
Segment Operating Income:
Product ID		$	(234	)		$	(13,076	)		$	(472	)		$	(11,860	)
Aerospace			2,337				1,885				9,763				9,087
Total Segment Operating Income		$	2,103			$	(11,191	)		$	9,291			$	(2,773	)
Segment Operating Margin:
Product ID			(0.9	)%			(50.9	)%			(0.5	)%			(11.6	)%
Aerospace			20.9	%			16.1	%			21.1	%			18.6	%
Total Segment Operating Margin			5.6	%			(30.0	)%			6.2	%			(1.8	)%
Corporate Expense			(2,049	)			(1,120	)			(8,085	)			(5,867	)
Operating Income (Loss)		$	54			$	(12,311	)		$	1,206			$	(8,640	)
Interest Expense		$	894			$	847			$	3,503			$	3,210
Other (Income)/Expense, net			(51	)			100				239				437
Income (Loss) Before Income Taxes		$	(788	)		$	(13,259	)		$	(2,536	)		$	(12,287	)
Income Tax Provision (Benefit)			346				2,342				(160	)			2,202
Net Income (Loss)		$	(1,134	)		$	(15,600	)		$	(2,376	)		$	(14,489	)

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 11 of 19

ASTRONOVA, INC.

Segment Sales and Non-GAAP Profit

(Unaudited, $ in thousands)

		Three Months Ended								Twelve Months Ended
($ in thousands)		January 31, 2026				January 31, 2025				January 31, 2026				January 31, 2025
Revenue:
Product ID		$	26,330			$	25,678			$	104,221			$	102,345
Aerospace			11,206				11,683				46,294				48,938
Total Revenue		$	37,536			$	37,361			$	150,515			$	151,283
Non-GAAP Gross Profit:
Product ID		$	7,356			$	8,296			$	31,010			$	32,770
Aerospace			4,547				3,989				17,961				18,087
Non-GAAP Gross Profit		$	11,903			$	12,285			$	48,971			$	50,857
Non-GAAP Gross Profit Margin:
Product ID			27.9	%			32.3	%			29.8	%			32.0	%
Aerospace			40.6	%			34.1	%			38.8	%			37.0	%
Non-GAAP Gross Profit Margin			31.7	%			32.9	%			32.5	%			33.6	%
Non-GAAP Segment Operating Income:
Product ID		$	(124)			$	647			$	1,542			$	2,966
Aerospace			2,648				1,886				9,934				9,088
Total Non-GAAP Segment Operating Income		$	2,524			$	2,533			$	11,476			$	12,054
Non-GAAP Segment Operating Margin:
Product ID			(0.5)	%			2.5	%			1.5	%			2.9	%
Aerospace			23.6	%			16.1	%			21.5	%			18.6	%
Total Non-GAAP Segment Operating Margin			6.7	%			6.8	%			7.6	%			8.0	%
Corporate Expense			(1,400)				(1,123)				(5,882)				(5,437)
Non-GAAP Operating Income		$	1,124			$	1,409			$	5,594			$	6,617
Interest Expense		$	894			$	847			$	3,503			$	3,210
Other (Income)/Expense, net			(51)				100				28				437
Income Before Income Taxes		$	281			$	462			$	2,063			$	2,970
Adjusted Income Tax Provision (Benefit)			586				43				845				284
Non-GAAP Net Income		$	(305)			$	419			$	1,218			$	2,686

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 12 of 19

ASTRONOVA, INC.

Revenue by Market

(unaudited, $ in thousands)

Product ID:		Q1 FY25				Q2 FY25				Q3 FY25				Q4 FY25				FY2025				Q1 FY26				Q2 FY26				Q3 FY26				Q4 FY26				FY2026
Desktop Label Printers		$	14,220			$	16,349			$	15,408			$	14,019			$	59,996			$	15,478			$	15,190			$	16,115				15,041				61,824
Mail & Sheet/Flat Pack Printers			3,930				3,471				3,679				4,494				15,574				4,050				3,740				4,280				4,138				16,208
Professional Label Printers			3,245				4,231				3,423				2,972				13,871				3,247				3,506				3,636				3,863				14,252
Direct to Package/Overprint Printers			1,787				2,925				3,627				2,718				11,057				3,396				2,230				2,371				2,579				10,576
Flexible Packaging Printers			—				—				15				1,289				1,304				30				69				79				38				216
Other			3				189				165				186				543				88				19				368				670				1,145
TOTAL		$	23,185			$	27,165			$	26,317			$	25,678			$	102,345			$	26,289			$	24,754			$	26,849				26,330				104,221
Aerospace:		Q1 FY25				Q2 FY25				Q3 FY25				Q4 FY25				FY2025				Q1 FY26*				Q2 FY26				Q3 FY26				Q4 FY26				FY2026
Commercial Aircraft		$	3,813			$	6,299			$	5,221			$	4,363			$	19,696			$	4,953			$	4,714			$	5,764			$	5,030			$	20,461
Aftermarket			4,694				5,326				7,058				5,481				22,559				4,911				4,953				4,955				4,831				19,650
Defense			329				608				734				781				2,452				811				1,047				766				885				3,509
Regional and Biz Jet Aircraft			697				604				993				802				3,096				396				431				634				195				1,656
Other			243				537				99				256				1,135				348				203				201				266				1,018
TOTAL		$	9,776			$	13,374			$	14,105			$	11,683			$	48,938			$	11,419			$	11,348			$	12,320			$	11,206			$	46,294
Consolidated Total		$	32,961			$	40,539			$	40,422			$	37,361			$	151,283			$	37,708			$	36,102			$	39,169				37,536				150,515

* Q1 fiscal 2026 revenue by market has been revised from amount previously reported in our Q1 fiscal 2026 press release issued on June 5, 2025, to correct a classification error between market categories. Total Q1 fiscal sales were unaffected.

ASTRONOVA, INC.

Revenue by Type

(unaudited, $ in thousands)

Product ID		Q1 FY25				Q2 FY25				Q3 FY25				Q4 FY25				FY 2025				Q1 FY26				Q2 FY26				Q3 FY26				Q4 FY26				FY 2026
Product ID HW		$	3,802			$	4,311			$	4,590			$	5,591			$	18,294			$	4,776			$	4,511			$	5,357			$	5,332			$	19,976
Product ID Recurring Supplies, Parts & Service			19,383				22,854				21,727				20,087				84,051				21,513				20,243				21,492				20,997				84,245
Total Product ID		$	23,185			$	27,165			$	26,317			$	25,678			$	102,345			$	26,289			$	24,754			$	26,849			$	26,330			$	104,221
Aerospace
Aerospace HW		$	5,073			$	8,048			$	7,032			$	6,185			$	26,338			$	6,519			$	6,425			$	7,360			$	6,369			$	26,673
Aerospace Recurring Supplies, Parts & Service			4,703				5,326				7,073				5,498				22,600				4,900				4,923				4,960				4,838				19,621
Total Aerospace		$	9,776			$	13,374			$	14,105			$	11,683			$	48,938			$	11,419			$	11,348			$	12,320			$	11,206			$	46,294
Consolidated
AstroNova HW		$	8,875			$	12,359			$	11,622			$	11,776			$	44,632			$	11,295			$	10,936			$	12,717			$	11,701			$	46,649
AstroNova Recurring Supplies, Parts & Service			24,086				28,180				28,800				25,585				106,651				26,413				25,166				26,452				25,835				103,866
TOTAL		$	32,961			$	40,539			$	40,422			$	37,361			$	151,283			$	37,708			$	36,102			$	39,169			$	37,536			$	150,515

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 13 of 19

ASTRONOVA, INC.

Bookings and Backlog

(unaudited, $ in thousands)

AstroNova

		Q1 FY25				Q2 FY25				Q3 FY25				Q4 FY25				FY 2025				Q1 FY26				Q2 FY26				Q3 FY26				Q4 FY26				FY 2026
Beginning backlog (Non-MTEX)		$	31,394			$	31,556			$	29,900			$	27,093			$	31,394			$	28,307			$	25,491			$	25,291			$	21,989			$	28,307
MTEX*		$	—			$	3,084			$	—			$	—			$	3,084			$	—			$	—			$	—			$	—			$	—
Backlog Beginning of Period (incl. MTEX)		$	31,394			$	34,640			$	29,900			$	27,093			$	34,478			$	28,307			$	25,491			$	25,291			$	21,989			$	28,307
Revenue Recognized (Billings)		$	32,961			$	40,539			$	40,422			$	37,361			$	151,283			$	37,708			$	36,102			$	39,169			$	37,536			$	150,515
New Bookings During Period		$	33,122			$	35,799			$	37,615			$	38,576			$	145,112			$	34,893			$	35,901			$	35,867			$	41,077			$	147,738
Backlog End of Period		$	31,556			$	29,900			$	27,093			$	28,307			$	28,307			$	25,491			$	25,291			$	21,989			$	25,530			$	25,530
Book/Bill %			100	%			88	%			93	%			103	%			96	%			93	%			99	%			92	%			109	%			96	%

* MTEX Backlog was acquired during 2nd quarter fiscal 2025

Product Identification

		Q1 FY25				Q2 FY25				Q3 FY25				Q4 FY25				FY 2025				Q1 FY26				Q2 FY26				Q3 FY26				Q4 FY26				FY 2026
Beginning backlog (Non-MTEX)		$	19,725			$	19,467			$	18,786			$	19,254			$	19,725			$	18,091			$	18,044			$	16,727			$	12,351			$	18,091
MTEX*		$	—			$	3,084			$	—			$	—			$	3,084			$	—			$	—			$	—			$	—			$	—
Backlog Beginning of Period (incl. MTEX)		$	19,725			$	22,551			$	18,786			$	19,254			$	22,809			$	18,091			$	18,044			$	16,727			$	12,351			$	18,091
Revenue Recognized (Billings)		$	23,185			$	27,165			$	26,317			$	25,678			$	102,345			$	26,289			$	24,754			$	26,849			$	26,330			$	104,221
New Bookings During Period		$	22,926			$	23,400			$	26,785			$	24,516			$	97,627			$	26,242			$	23,437			$	22,473			$	27,460			$	99,612
Backlog End of Period		$	19,467			$	18,786			$	19,254			$	18,091			$	18,091			$	18,044			$	16,727			$	12,351			$	13,484			$	13,482
Book/Bill %			99	%			86	%			102	%			95	%			95	%			100	%			95	%			84	%			104	%			95	%

* MTEX Backlog was acquired during 2nd quarter fiscal 2025

Aerospace

		Q1 FY25				Q2 FY25				Q3 FY25				Q4 FY25				FY 2025				Q1 FY26				Q2 FY26				Q3 FY26				Q4 FY26				FY 2025
Backlog Beginning of Period		$	11,669			$	12,089			$	11,114			$	7,839			$	11,669			$	10,216			$	7,447			$	8,563			$	9,638			$	10,216
Revenue Recognized (Billings)		$	9,776			$	13,374			$	14,105			$	11,683			$	48,938			$	11,419			$	11,348			$	12,320			$	11,206			$	46,294
New Bookings During Period		$	10,196			$	12,399			$	10,830			$	14,060			$	47,485			$	8,651			$	12,464			$	13,394			$	13,617			$	48,126
Backlog End of Period		$	12,089			$	11,114			$	7,839			$	10,216			$	10,216			$	7,447			$	8,563			$	9,638			$	12,047			$	12,048
Book/Bill %			104	%			93	%			77	%			120	%			97	%			76	%			110	%			109	%			122	%			97	%

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 14 of 19

ASTRONOVA, INC.

Segment Sales and Profit – Historical Quarterly Summary (Recast)

(unaudited, $ in thousands)

				FY24				Q1				Q2				Q3				Q4				FY25				Q1				Q2				Q3				Q4				FY26
		Revenue		$	44,045				9,776				13,374				14,105				11,683			$	48,938				11,419				11,348				12,320				11,206			$	46,294
		Gross profit		$	15,900				3,456				5,548				5,093				3,989			$	18,087				3,719				3,721				6,121				4,236			$	17,797
		Gross Profit Margin			36.1	%			35.4	%			41.5	%			36.1	%			34.1	%			37.0	%			32.6	%			32.8	%			49.7	%			37.8	%			38.4	%
		Operating Expenses:
		Selling & Marketing		$	3,433				904				899				913				822			$	3,537				481				911				1,095				772			$	3,260
		Research & Development		$	2,347				801				781				877				785			$	3,243				652				603				710				656			$	2,621
		General & Administrative		$	1,881				644				567				512				497			$	2,220				606				540				536				471			$	2,154
		Total Operating Expenses		$	7,661				2,348				2,246				2,301				2,104			$	9,000				1,739				2,055				2,341				1,899			$	8,034
		Aerospace Operating Income		$	8,240				1,108				3,302				2,792				1,885			$	9,087				1,980				1,666				3,780				2,338			$	9,763
		Aerospace Operating Margin			18.7	%			11.3	%			24.7	%			19.8	%			16.1	%			18.6	%			17.3	%			14.7	%			30.7	%			20.9	%			21.1	%
		Non-GAAP
		Aerospace Adjusted EBITDA1		$	10,239				1,519				3,719				3,193				2,279			$	10,710				2,566				2,081				3,911				3,104			$	11,662
		Adjusted EBITDA Margin1			23.2	%			15.5	%			27.8	%			22.6	%			19.5	%			21.9	%			22.5	%			18.3	%			31.7	%			27.7	%			25.2	%
					FY24				Q1				Q2				Q3				Q4				FY25				Q1				Q2				Q3				Q4				FY26
			Revenue		$	104,041				23,185				27,165				26,317				25,679			$	102,345				26,289				24,754				26,849				26,330			$	104,221
			Gross profit		$	33,604				8,002				8,315				8,015				8,236			$	32,570				8,232				7,194				7,323				7,088			$	29,838
		Gross Profit Margin			32.3	%			34.5	%			30.6	%			30.5	%			32.1	%			31.8	%			31.3	%			29.1	%			27.3	%			26.9	%			28.6	%
		Operating Expenses:
		Selling & Marketing		$	19,971				4,436				5,567				5,438				5,274			$	20,715				5,124				4,935				4,773				4,870			$	19,703
		Research & Development		$	3,994				670				507				795				832			$	2,804				877				961				1,188				1,141			$	4,167
		General & Administrative		$	4,314				1,447				2,363				1,896				15,206			$	20,911				1,971				1,490				1,667				1,310			$	6,439
		Total Operating Expenses		$	28,280				6,553				8,437				8,128				21,312			$	44,430				7,973				7,387				7,628				7,323			$	30,310
		Product ID Operating Income		$	5,325				1,449				(121	)			(112	)			(13,076	)		$	(11,860	)			259				(192	)			(304	)			(234	)		$	(472	)
		Product ID Operating Margin			5.1	%			6.2	%			(0.4	)%			(0.4	)%			(50.9	)%			(11.6	)%			1.0	%			(0.8	)%			(1.1	)%			(0.9	)%			(0.5	)%
		Non-GAAP
		Product ID Adjusted EBITDA1		$	11,156				2,046				1,619				1,269				1,615			$	6,550				1,902				870				1,371				1,095			$	5,238
		Adjusted EBITDA Margin1			10.7	%			8.8	%			6.0	%			4.8	%			6.3	%			6.4	%			7.2	%			3.5	%			5.1	%			4.2	%			5.0	%
		Corporate Expense		$	4,768				1,211				2,120				1,416				1,120			$	5,867				1,668				2,181				2,187				2,049			$	8,086
			Consolidated Operating Income			8,796				1,346				1,061				1,264				(12,311	)			(8,640	)			571				(708	)			1,288				55				1,206
			Consolidated Operating Margin			5.9	%			4.1	%			2.6	%			3.1	%			(33.0	)%			(5.7	)%			1.5	%			(2.0	)%			3.3	%			0.1	%			0.8	%
			Non-GAAP
			Adjusted EBITDA1		$	17,601				2,463				3,849				3,230				2,793			$	12,336				3,146				2,056				4,173				3,306			$	12,681
		Adjusted EBITDA Margin1			11.9	%			7.5	%			9.5	%			8.0	%			7.5	%			8.2	%			8.3	%			5.7	%			10.7	%			8.8	%			8.4	%

⁽¹⁾  Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP metrics. Please refer to the reconciliation of GAAP to non-GAAP metrics in the tables that accompany this news release.

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 15 of 19

ASTRONOVA, INC.

Reconciliation of GAAP to Non-GAAP Items

(Unaudited, $ in thousands)

		Three Months Ended								Twelve Months Ended								2H Fiscal 2026 and 1H Fiscal 2026
		January 31, 2026				January 31, 2025				January 31, 2026				January 31, 2025				2H FY26				1H FY26
Revenue		$	37,536			$	37,361			$	150,515			$	151,283			$	76,705			$	73,810
Gross Profit		$	11,324			$	12,227			$	47,634			$	50,658			$	24,769			$	22,866
Inventory Step-Up			—				62				61				216				—				61
Inventory Provision			365				—				724				—				724				—
Restructuring Charges			29				—				367				—				30				337
Product Retrofit Costs			185				—				185				—				185				—
Non-GAAP Gross Profit		$	11,903			$	12,289			$	48,971			$	50,874			$	25,708			$	23,264
Gross Profit Margin			30.2	%			32.7	%			31.6	%			33.5	%			32.3	%			31.0	%
Non-GAAP Gross Profit Margin			31.7	%			32.9	%			32.5	%			33.6	%			33.5	%			31.5	%
Operating Expenses		$	11,270			$	24,538			$	46,428			$	59,298			$	23,426			$	23,003
MTEX-related Acquisition Expenses			—				(254	)			(311	)			(1,204	)			—				(311	)
CFO Transition Costs			—				—				—				(432	)			—				—
Restructuring Charges			(23	)			—				(990	)			—				(81	)			(910	)
Non-Recurring Legal Expenses			(258	)			—				(715	)			—				(646	)			(69	)
Non-Recurring Proxy Costs			(210	)			—				(738	)			—				(383	)			(355	)
Goodwill Impairment			—				(13,403	)			(297	)			(13,403	)			(297	)			—
Non-GAAP Operating Expenses		$	10,779			$	10,881			$	43,377			$	44,259			$	22,019			$	21,358
Operating Income (Loss)		$	54			$	(12,311	)		$	1,206			$	(8,640	)		$	1,342			$	(137	)
MTEX-related Acquisition Expenses			—				254				311				1,204				—				311
CFO Transition Costs			—				—				—				432				—				—
Inventory Step-Up			—				62				61				216				—				61
Inventory Provision			365				—				724				—				724				—
Restructuring Charges			52				—				1,357				—				110				1,247
Product Retrofit Costs			185				—				185				—				186				—
Non-Recurring Legal Expenses			258				—				715				—				646				69
Non-Recurring Proxy Costs			210				—				738				—				383				355
Goodwill Impairment			—				13,403				297				13,403				297				—
Non-GAAP Operating Income		$	1,124			$	1,408			$	5,594			$	6,615			$	3,688			$	1,906
Operating Income Margin			0.1	%			(33.0	)%			0.8	%			(5.7	)%			1.7	%			(0.2	)%
Non-GAAP Operating Income Margin			3.0	%			3.8	%			3.7	%			4.4	%			4.8	%			2.6	%
Net Income (Loss)		$	(1,134	)		$	(15,600	)		$	(2,376	)		$	(14,489	)		$	(756	)		$	(1,620	)
MTEX-related Acquisition Expenses(1)			—				197				237				910				—				237
CFO Transition Costs, net(1)			—				(4	)			—				328				—				—
Inventory Step-Up(1)			—				50				49				161				—				49
Inventory Provision(1)			292				—				565				—				565				—
Restructuring Charges(1)			41				—				1,030				—				80				950
Product Retrofit Costs(1)			148				—				148				—				148				—
Non-Recurring Legal Expenses(1)			189				—				542				—				489				53
Non-Recurring Proxy Costs(1)			160				—				561				—				289				272
Realized Fx(1)			—				—				80				—				80				—
Other (Income) and Expense(1)			—				—				85				—				85				—
Goodwill Impairment			—				13,403				297				13,403				297				—
Tax Provision Valuation Allowance			—				2,373				—				2,373				—				—
Non-GAAP Net Income (Loss)		$	(305	)		$	419			$	1,218			$	2,686			$	1,277			$	(59	)
Diluted Earnings (Loss) Per Share		$	(0.15	)		$	(2.07	)		$	(0.31	)		$	(1.93	)		$	(0.10	)		$	(0.21	)
MTEX-related Acquisition Expenses(1)			—				0.03				0.03				0.12				—				0.03
CFO Transition Costs, net(1)			—				(0.00	)			—				0.04				—				—
Inventory Step-Up(1)			—				0.01				0.01				0.02				—				0.01
Inventory Provision(1)			0.04				—				0.07				—				0.07				—
Restructuring Charges(1)			0.01				—				0.14				—				0.01				0.13
Product Retrofit Costs(1)			0.02				—				0.02				—				0.02				—
Non-Recurring Legal Expenses(1)			0.02				—				0.07				—				0.06				0.01
Non-Recurring Proxy Costs(1)			0.02				—				0.07				—				0.04				0.04
Realized Fx(1)			—				—				0.01				—				0.01				—
Other (Income) and Expense(1)			—				—				0.01				—				0.01				—
Goodwill Impairment(1)			—				1.78				0.04				1.76				0.04				—
Tax Provision Valuation Allowance			—				0.31				—				0.31				—				—
Non-GAAP Diluted Earnings (Loss) Per Share		$	(0.04	)		$	0.06			$	0.16			$	0.32			$	0.16			$	(0.01	)

⁽¹⁾  Net of taxes

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 16 of 19

ASTRONOVA INC.

Reconciliation of Net Income and Margin to Adjusted EBITDA and Margin

(Unaudited, $ in thousands)

		Three Months Ended
		January 31, 2026				January 31, 2025
Net Income (Loss)		$	(1,134	)		$	(15,600	)
Interest Expense			894				847
Income Tax Expense (Benefit)			346				2,342
Depreciation & Amortization			1,379				1,266
EBITDA		$	1,485			$	(11,145	)
Share-Based Compensation			752				219
MTEX-related Acquisition Expenses			—				259
CFO Transition Costs			—				(5	)
Inventory Step-Up			—				62
Inventory Provision			365				—
Restructuring Charges			52				—
Product Retrofit Costs			185				—
Non-Recurring Legal Expenses			258				—
Non-Recurring Proxy Costs			210				—
Goodwill Impairment			—				13,403
Adjusted EBITDA		$	3,306			$	2,794
Revenue		$	37,536			$	37,361
Net Income (Loss) Margin			(3.0	)%			(41.8	)%
Adjusted EBITDA Margin			8.8	%			7.5	%

		Twelve Months Ended								2H Fiscal 2026 and 1H 2026
		January 31, 2026				January 31, 2025				2H FY26				1H FY26
Net Income (Loss)		$	(2,376	)		$	(14,489	)		$	(757	)		$	(1,619	)
Interest Expense			3,503				3,210				1,721				1,782
Income Tax Expense (Benefit)			(160	)			2,202				218				(378	)
Depreciation & Amortization			4,804				4,780				2,234				2,570
EBITDA		$	5,771			$	(4,297	)		$	3,418			$	2,355
Share-Based Compensation			2,310				1,378				1,505				805
MTEX-related Acquisition Expenses			311				1,204				—				311
CFO Transition Costs			—				432				—				—
Inventory Step-Up			61				216				—				61
Inventory Provision			724				—				724				—
Restructuring Charges			1,357				—				110				1,247
Product Retrofit Costs			185				—				185				—
Non-Recurring Legal Expenses			715				—				646				69
Non-Recurring Proxy Costs			738				—				383				355
Realized Fx			100				—				100				—
Other (Income) and Expense			112				—				112				—
Goodwill Impairment			297				13,403				297				—
Adjusted EBITDA		$	12,681			$	12,336			$	7,478			$	5,203
Revenue		$	150,515			$	151,283			$	76,705			$	73,810
Net Income (Loss) Margin			(1.6	)%			(9.6	)%			(1.0	)%			(2.2	)%
Adjusted EBITDA Margin			8.4	%			8.2	%			9.7	%			7.0	%

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 17 of 19

ASTRONOVA INC.

Reconciliation of Segment Gross Profit and Margin to Non-GAAP Gross Profit and Margin

(Unaudited, $ in thousands)

		Three Months Ended
		January 31, 2026												January 31, 2025
		Product ID				Aerospace				Total				Product ID				Aerospace				Total
Segment Gross Profit		$	7,088			$	4,237			$	11,325			$	8,237			$	3,989			$	12,226
Inventory Step-Up			—				—				—				62				—				62
Inventory Provision			54				311				365				—				—				—
Product Retrofit Costs			185				—				185				—				—				—
Restructuring Charges			29				—				29				—				—				—
Non-GAAP - Segment Gross Profit		$	7,356			$	4,548			$	11,904			$	8,299			$	3,989			$	12,288
Revenue		$	26,330			$	11,206			$	37,536			$	25,678			$	11,683			$	37,361
Gross Profit Margin			26.9	%			37.8	%			30.2	%			32.1	%			34.1	%			32.7	%
Non-GAAP Segment Gross Profit Margin			27.9	%			40.6	%			31.7	%			32.3	%			34.1	%			32.9	%
		Twelve Months Ended
		January 31, 2026												January 31, 2025
		Product ID				Aerospace				Total				Product ID				Aerospace				Total
Segment Gross Profit		$	29,837			$	17,797			$	47,634			$	32,571			$	18,087			$	50,658
Inventory Step-Up			61				—				61				216				—				216
Inventory Provision			724				—				724				—				—				—
Product Retrofit Costs			185				—				185				—				—				—
Restructuring Charges			202				165				367				—				—				—
Non-GAAP - Segment Gross Profit		$	31,009			$	17,962			$	48,971			$	32,787			$	18,087			$	50,874
Revenue		$	104,221			$	46,294			$	150,515			$	102,345			$	48,938			$	151,283
Gross Profit Margin			28.6	%			38.4	%			31.6	%			31.8	%			37.0	%			33.5	%
Non-GAAP Segment Gross Profit Margin			29.8	%			38.8	%			32.5	%			32.0	%			37.0	%			33.6	%

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 18 of 19

ASTRONOVA INC.

Reconciliation of Segment Operating Profit and Margin to Non-GAAP Operating Profit and Margin

(Unaudited, $ in thousands)

		Three Months Ended
		January 31, 2026												January 31, 2025
		Product ID				Aerospace				Total				Product ID				Aerospace				Total
Segment Operating Income (Loss)		$	(234	)		$	2,337			$	2,103			$	(13,075	)		$	1,886			$	(11,189	)
MTEX-related Acquisition Expenses			—				—				—				259				—				259
Inventory Step-Up			—				—				—				62				—				62
Inventory Provision			54				311				365				—				—				—
Product Retrofit Costs			185				—				185				—				—				—
Restructuring Charges			52				—				52				—				—				—
Non-Recurring Legal Expenses			(181	)			—				(181	)			—				—				—
Goodwill Impairment			—				—				—				13,403				—				13,403
Non-GAAP - Segment Operating Income (Loss)		$	(124	)		$	2,648			$	2,524			$	649			$	1,886			$	2,535
Revenue		$	26,330			$	11,206			$	37,536			$	25,678			$	11,683			$	37,361
Operating Margin			(0.9	)%			20.9	%			5.6	%			(50.9	)%			16.1	%			(29.9	)%
Non-GAAP Operating Margin			(0.5	)%			23.6	%			6.7	%			2.5	%			16.1	%			6.8	%
		Twelve Months Ended
		January 31, 2026												January 31, 2025
		Product ID				Aerospace				Total				Product ID				Aerospace				Total
Segment Operating Income (Loss)		$	(471	)		$	9,763			$	9,292			$	(11,860	)		$	9,088			$	(2,772	)
MTEX-related Acquisition Expenses			311				—				311				1,204				—				1,204
Inventory Step-Up			61				—				61				216				—				216
Inventory Provision			724				—				724				—				—				—
Product Retrofit Costs			185				—				185				—				—				—
Restructuring Charges			483				171				654				—				—				—
Non-Recurring Legal Expenses			(48	)			—				(48	)			—				—				—
Goodwill Impairment			297				—				297				13,403				—				13,403
Non-GAAP - Segment Operating Income		$	1,542			$	9,934			$	11,476			$	2,963			$	9,088			$	12,051
Revenue		$	104,221			$	46,294			$	150,515			$	102,345			$	48,938			$	151,283
Operating Margin			(0.5	)%			21.1	%			6.2	%			(11.6	)%			18.6	%			(1.8	)%
Non-GAAP Operating Margin			1.5	%			21.5	%			7.6	%			2.9	%			18.6	%			8.0	%

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 19 of 19

ASTRONOVA INC.

Reconciliation of Segment and Consolidated Net Income to Adjusted EBITDA (Past Quarters and Years)

(Unaudited, $ in thousands)

				2024				Q1 25				Q2 25				Q3 25				Q4 25				FY25				Q1 26				Q2 26				Q3 26				Q4 26				FY26
		Operating Income		$	8,240			$	1,108			$	3,302			$	2,792			$	1,886			$	9,088			$	1,980			$	1,666			$	3,780			$	2,338			$	9,763
		Other			—				—				—				—				—				—				—				—				—				—				—
		Interest expense			—				—				—				—				—				—				—				—				—				—				—
		Profit Before Tax		$	8,240				1,108				3,302				2,792				1,886			$	9,088				1,980				1,666				3,780				2,338			$	9,763
		Tax			—				—				—				—				—				—				—				—				—				—				—
		Net Income		$	8,240				1,108				3,302				2,792				1,886			$	9,088				1,980				1,666				3,780				2,338			$	9,763
		Depreciation & Amortization			1,873				374				378				365				365				1,482				373				368				363				360				1,464
		Share-Based Compensation			126				37				39				36				29				140				43				46				80				94				263
		Inventory Provision			—				—				—				—				—				—				—				—				(311	)			311				—
		Restructuring Charges			—				—				—				—				—				—				170				1				—				—				171
		Adjusted EBITDA		$	10,239			$	1,519			$	3,719			$	3,193			$	2,279			$	10,710			$	2,566			$	2,081			$	3,911			$	3,104			$	11,662
		Revenue		$	44,045			$	9,776			$	13,374			$	14,105			$	11,683			$	48,938			$	11,419			$	11,348			$	12,320			$	11,206			$	46,294
		Adjusted EBITDA Margin			23.2	%			15.5	%			27.8	%			22.6	%			19.5	%			21.9	%			22.5	%			18.3	%			31.7	%			27.7	%			25.2	%
				2024				Q1 25				Q2 25				Q3 25				Q4 25				FY25				Q1 26				Q2 26				Q3 26				Q4 26				FY26
			Operating Income		$	5,325			$	1,449			$	(121	)		$	(113	)		$	(13,075	)		$	(11,860	)		$	259			$	(192	)		$	(304	)		$	(234	)		$	(471	)
			Other			—				—				—				—				—				—				—				—				—				—				—
			Interest expense			—				—				—				—				—				—				—				—				—				—				—
		Profit Before Tax		$	5,325				1,449				(121	)			(113	)			(13,075	)		$	(11,860	)			259				(192	)			(304	)			(234	)		$	(471	)
		Tax			—				—				—				—				—				—				—				—				—				—				—
		Net Income		$	5,325				1,449				(121	)			(113	)			(13,075	)		$	(11,860	)			259				(192	)			(304	)			(234	)		$	(471	)
		Interest expense			—				—				—				—				—				—				—				—				—				—				—
		Tax			—				—				—				—				—				—				—				—				—				—				—
		Depreciation & Amortization			2,378				532				921				929				896				3,279				913				909				489				1,013				3,322
		Share-Based Compensation			317				64				74				94				75				308				(7	)			86				88				207				373
		MTEX-related Acquisition Expenses			—				—				625				325				254				1,204				337				(26	)			—				—				311
		Inventory Step-Up			—				—				120				34				62				216				61				—				—				—				61
		Inventory Provision			—				—				—				—				—				—				—				—				670				54				724
		Restructuring Charges			2,494				—				—				—				—				—				339				94				(2	)			52				483
		Product Retrofit Costs			642				—				—				—				—				—				—				—				—				185				185
		Non-Recurring Legal Expenses			—				—				—				—				—				—				—				—				134				(182	)			(48	)
		Goodwill Impairment			—				—				—				—				13,403				13,403				—				—				297				—				297
		Adjusted EBITDA			11,156				2,046				1,619				1,269				1,615				6,550				1,902				870				1,371				1,095				5,238
		Revenue		$	104,041			$	23,185			$	27,165			$	26,317			$	25,679			$	102,345			$	26,289			$	24,754			$	26,849			$	26,330			$	104,221
		Adjusted EBITDA Margin			10.7	%			8.8	%			6.0	%			4.8	%			6.3	%			6.4	%			7.2	%			3.5	%			5.1	%			4.2	%			5.0	%
					2024				Q1 25				Q2 25				Q3 25				Q4 25				FY25				Q1 26				Q2 26				Q3 26				Q4 26				FY26
			Operating Income		$	(4,768	)		$	(1,211	)		$	(2,120	)		$	(1,416	)		$	(1,122	)		$	(5,869	)		$	(1,668	)		$	(2,181	)		$	(2,187	)		$	(2,050	)		$	(8,087	)
			Other			26				118				173				46				100				437				(24	)			104				210				(51	)			239
			Interest expense			2,697				482				938				944				847				3,210				897				885				827				894				3,503
		Profit Before Tax		$	(7,491	)			(1,811	)			(3,231	)			(2,406	)			(2,069	)		$	(9,516	)			(2,541	)			(3,170	)			(3,224	)			(2,893	)		$	(11,829	)
		Tax			1,379				(434	)			261				34				2,342				2,203				75				(454	)			(128	)			346				(161	)
		Net Income		$	(8,870	)			(1,377	)			(3,492	)			(2,440	)			(4,411	)		$	(11,719	)			(2,616	)			(2,716	)			(3,096	)			(3,239	)		$	(11,668	)
		Interest expense			2,697				482				938				944				847				3,210				897				885				827				894				3,503
		Tax			1,379				(434	)			261				36				2,342				2,205				75				(454	)			(128	)			346				(161	)
		Depreciation & Amortization			15				4				4				6				4				19				4				4				5				5				18
		EBITDA		$	(4,779	)			(1,324	)			(2,289	)			(1,454	)			(1,218	)		$	(6,285	)			(1,640	)			(2,282	)			(2,392	)			(1,994	)		$	(8,308	)
		Share-Based Compensation			903				223				368				222				116				929				270				367				586				449				1,673
		CFO Transition Costs			—				—				432				—				—				432				—				—				—				—				—
		Restructuring Charges			82				—				—				—				—				—				49				595				60				—				703
		Non-Recurring Legal Expenses			—				—				—				—				—				—				—				69				254				440				763
		Non-Recurring Proxy Costs			—				—				—				—				—				—				—				355				172				210				738
		Realized Fx			—				—				—				—				—				—				—				—				100				—				100
		Other (Income) and Expense			—				—				—				—				—				—				—				—				112				—				112
		Adjusted EBITDA		$	(3,794	)		$	(1,101	)		$	(1,489	)		$	(1,232	)		$	(1,102	)		$	(4,924	)		$	(1,321	)		$	(896	)		$	(1,108	)		$	(895	)		$	(4,220	)
					2024				Q1 25				Q2 25				Q3 25				Q4 25				FY25				Q1 26				Q2 26				Q3 26				Q4 26				FY26
			Operating Income		$	8,796			$	1,346			$	1,061			$	1,263			$	(12,311	)		$	(8,641	)		$	571			$	(708	)		$	1,288			$	55			$	1,207
			Other			26				118				173				46				100				437				(24	)			104				210				(51	)			239
			Interest expense			2,697				482				938				944				847				3,210				897				885				827				894				3,503
		Profit Before Tax		$	6,073				746				(50	)			273				(13,258	)		$	(12,288	)			(302	)			(1,697	)			251				(789	)		$	(2,536	)
		Tax			1,379				(434	)			261				34				2,342				2,202				75				(454	)			(128	)			346				(161	)
		Net Income		$	4,694				1,180				(311	)			239				(15,600	)		$	(14,490	)			(377	)			(1,243	)			379				(1,134	)		$	(2,374	)
		Interest expense			2,697				482				938				944				847				3,210				897				885				827				894				3,503
		Tax			1,379				(434	)			261				36				2,342				2,202				75				(454	)			(128	)			346				(161	)
		Depreciation & Amortization			4,266				911				1,304				1,300				1,266				4,780				1,290				1,280				856				1,379				4,805
		EBITDA		$	13,036				2,139				2,191				2,519				(11,146	)		$	(4,297	)			1,885				469				1,934				1,485			$	5,773
		Share-Based Compensation			1,347				325				481				352				219				1,378				306				499				754				751				2,310
		MTEX-related Acquisition Expenses			—				—				625				325				254				1,204				337				(26	)			—				—				311
		CFO Transition Costs			—				—				432				—				—				432				—				—				—				—				—
		Inventory Step-Up			—				—				120				34				62				216				61				—				—				—				61
		Inventory Provision			—				—				—				—				—				—				—				—				359				365				724
		Restructuring Charges			2,576				—				—				—				—				—				558				689				59				52				1,357
		Product Retrofit Costs			642				—				—				—				—				—				—				—				—				185				185
		Non-Recurring Legal Expenses			—				—				—				—				—				—				—				69				387				258				715
		Non-Recurring Proxy Costs			—				—				—				—				—				—				—				355				172				210				738
		Realized Fx			—				—				—				—				—				—				—				—				100				—				100
		Other (Income) and Expense			—				—				—				—				—				—				—				—				112				—				112
		Goodwill Impairment			—				—				—				—				13,403				13,403				—				—				297				—				297
		Adjusted EBITDA		$	17,601			$	2,463			$	3,849			$	3,230			$	2,793			$	12,336			$	3,146			$	2,056			$	4,175			$	3,306			$	12,681
			Revenue		$	148,086			$	32,961			$	40,539			$	40,422			$	37,361			$	151,283			$	37,708			$	36,102			$	39,169			$	37,536			$	150,515
			Adjusted EBITDA Margin			11.9	%			7.5	%			9.5	%			8.0	%			7.5	%			8.2	%			8.3	%			5.7	%			10.7	%			8.8	%			8.4	%

Filing Exhibits & Attachments

4 documents

Press Releases

• EX-99.1 EX-99.1 976.8 KB

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 2.8 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 16.8 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 10.6 KB